Econ-Omics Talks: Should we conduct genomic screening for all adults? - June 25, 2024

Clinical and economic outcomes using simulation modeling:
Dr. Veenstra will present his research evaluating the benefits, risks, and costs of population-level genomic screening for adults. Drivers, barriers, and evidence gaps for both rare, high-risk genomic variants and more common moderate risk stratification approaches will be discussed. This presentation is part of the Econ-Omics Talks series and will include a brief speaker interview in addition to a research seminar.